Perrigo adds cherry-flavored cetirizine
This article was originally published in The Tan Sheet
FDA approves the private labeler's application to manufacture and market Cetirizine Cherry Syrup, 1 mg/mL - equivalent to Johnson & Johnson/McNeil's Zyrtec Children's Allergy Syrup. Perrigo's store-brand antihistamine will begin shipping to retailers by September, joining its current grape-flavored cetirizine syrup, Perrigo said July 26. The FDA approval is a good sign for Perrigo, as the application originated from the firm's Allegan, Mich., plant that elicited a warning letter in April due to quality system failings, Collins Stewart analyst Louise Chen said in a same-day note (1"The Tan Sheet" June 21, 2010). "We think that the FDA would not have approved a product out of Michigan if the agency felt there were substantive manufacturing issues at the facility," Chen wrote
You may also be interested in...
Perrigo wants FDA to re-inspect its Allegan, Mich., manufacturing plant in October, when the private labeler intends to have corrected its quality system failings that elicited a warning letter in April
The European Medicines Agency has accepted Biogen’s marketing authorization submission for its BIIB800, developed by Chinese firm Bio-Thera.
As part of BsUFA III, the FDA has announced that it will be commencing its regulatory science research program, which will focus on advancing the development of interchangeable products and biosimilars.